Markets
-
Asana Ranked a Leader in Collaborative Work Management, Q2 2025
Asana has been named a Leader in Forrester’s Collaborative Work Management (CWM) Tools, Q2 2025 report. The company received its highest score in the Strategy category, excelling in Vision, Innovation, and Roadmap. Asana’s vision focuses on human and AI collaboration, offering features like AI Studio and Smart Workflow Gallery to enhance productivity and streamline workflows. The platform aims to connect work with core objectives and provide transparency, supporting businesses navigating an AI-driven landscape.
-
Cyber Doc: Avoiding Overtreatment
The article explores the potential and pitfalls of AI in healthcare. While AI doctors promise improved precision, studies reveal they can amplify existing biases in treatment based on factors like income, gender, or race. Concerns about data quality and inherent biases within healthcare systems necessitate adjustments. The solution involves a shift from a disease-centered approach to a focus on the overall patient, alongside ongoing medical progress and the use of data.
-
Bubble Mart Outshines Hermès in American Eyes
POP MART’s LABUBU designer toys are experiencing immense global popularity, particularly in the US, fueled by celebrity endorsements and social media trends. Sales in the US market are booming, rivaling luxury goods. The craze has led to customization, high demand, and even the development of secondary industries. While successful, the company faces challenges in IP development and balancing product scarcity with market responsiveness.
-
Fly, Ride, Explore: JetBlue and Brightline Team Up for Florida Travel
JetBlue and Brightline have formed an intermodal alliance for streamlined travel in Florida. Customers can now book Brightline rail tickets directly on jetblue.com, creating combined itineraries. This integrated booking optimizes travel to and from cities like Miami, Fort Lauderdale, and Orlando with seamless air-rail transfers, offering convenience and enhanced customer recovery options during disruptions.
-
Can I Still Buy Xiaomi Stock for Around $7? Lei Jun’s Poetic Response
Xiaomi’s stock is trading around HK$53.2, nearing a previous high. Its P/E ratio of 54 indicates strong growth potential. Facing the question of whether to buy, CEO Lei Jun emphasizes Xiaomi’s improving fundamentals and long-term performance, expressing confidence in future growth for long-term investors.
-
Huawei’s F5G-A 10-Gigabit All-Optical Campus Solution Dominates, Leading China Market for Six Consecutive Years
According to IDC’s latest report on China’s Passive Optical LAN market, Huawei remains the market leader for the sixth consecutive year. The study projects steady growth with a 7.3% expansion in 2025 and an estimated RMB 2.52 billion market by 2029. Huawei’s F5G-A all-optical campus solution, featuring 50G PON and Wi-Fi 7, and its AI-powered FTTO Planner are key drivers of this growth.
-
Personalization Ups Customer Regret Risk at Key Journey Points, Gartner Finds
Gartner research indicates that traditional personalized marketing is backfiring. A survey of 1,464 B2B buyers and consumers reveals 53% report negative experiences, leading to purchase regret and future hesitancy. Active personalization, which proactively addresses customer needs through interactive methods, emerges as a superior strategy. It boosts customer confidence and ROI significantly, allowing customers to own their journey and fostering deeper engagement. Gartner recommends actively addressing journey pitfalls, catalyzing emotional change, and embracing customer co-creation for enhanced marketing outcomes.
-
Ant Group’s AI Health Assistant Passes Trustworthiness Assessment, Benefits 40 Million Users
Ant Group’s “AI Health Guardian” has passed CAICT’s trustworthiness evaluation for large-scale medical health models, confirming its reliability. Launched in September 2024, the AI-powered service provides doctor recommendations, health assessments, and more. It leverages a medical-focused language model and has already served 40 million users, demonstrating successful integration and collaboration within healthcare.
-
Xiaomi: Official YU7 Pricing to Be Announced Before Launch, No Pre-Set Prices
Xiaomi is combating speculation surrounding the pricing of its upcoming YU7 electric vehicle. The company issued a statement dismissing all circulating price estimates as unfounded, urging consumers to await official announcements. Company executives, including Wang Hua, emphasized pricing will only be confirmed just before the launch. Xiaomi also aims for its automotive division to achieve profitability this year, with significant investment in intelligent driving development.
-
Quantum BioPharma: Name Remains Unchanged
Quantum BioPharma (QNTM) addresses marketplace misinformation and provides an update on its Unbuzzd Wellness Inc. partnership. The company clarifies its identity and denies any reverse takeover with Unbuzzd, which is preparing for a potential IPO. QNTM holds a significant stake in Unbuzzd through royalties and shares, including an anti-dilution warrant. Other key items include the company’s loan to Unbuzzd, the debt settlement, and product news.